Compounds > fexinidazole
Page last updated: 2024-08-25

fexinidazole and Leishmaniasis, Visceral

fexinidazole has been researched along with Leishmaniasis, Visceral in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Rycker, M; Fairlamb, AH; Norval, S; Osuna-Cabello, M; Patterson, S; Perry, MR; Read, KD; Simeons, FR; Stojanovski, L; Wyllie, S1
Fairlamb, AH; Kime, R; Norval, S; Patterson, S; Read, KD; Simeons, FR; Stojanovski, L; Wyllie, S1
Fairlamb, AH; Patterson, S; Wyllie, S1

Other Studies

3 other study(ies) available for fexinidazole and Leishmaniasis, Visceral

ArticleYear
The R enantiomer of the antitubercular drug PA-824 as a potential oral treatment for visceral Leishmaniasis.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:10

    Topics: Animals; Antiprotozoal Agents; Antitubercular Agents; Female; Leishmaniasis, Visceral; Mice; Mice, Inbred BALB C; Nitroimidazoles; Stereoisomerism

2013
The anti-trypanosome drug fexinidazole shows potential for treating visceral leishmaniasis.
    Science translational medicine, 2012, Feb-01, Volume: 4, Issue:119

    Topics: Administration, Oral; Animals; Biotransformation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Leishmania donovani; Leishmaniasis, Visceral; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Nitroimidazoles; Nitroreductases; Parasitic Sensitivity Tests; Protozoan Proteins; Sulfones; Sulfoxides; Trypanocidal Agents

2012
Assessing the essentiality of Leishmania donovani nitroreductase and its role in nitro drug activation.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:2

    Topics: Cell Line; Drug Resistance; Gene Knockout Techniques; Leishmania donovani; Leishmaniasis, Visceral; Nitro Compounds; Nitroimidazoles; Nitroreductases; Trypanocidal Agents

2013